相似文献
1
Role of Salivary MicroRNA and Cytokines in the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
Int J Mol Sci. 2021 Nov 11;22(22):12215. doi: 10.3390/ijms222212215.
2
Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
J Proteomics. 2020 Feb 10;212:103574. doi: 10.1016/j.jprot.2019.103574. Epub 2019 Nov 7.
3
Identification of potential salivary biomarker panels for oral squamous cell carcinoma.
Sci Rep. 2021 Feb 9;11(1):3365. doi: 10.1038/s41598-021-82635-0.
4
Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review.
Int J Mol Sci. 2021 Jun 24;22(13):6795. doi: 10.3390/ijms22136795.
5
Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
Med Sci Monit. 2015 Aug 5;21:2275-81. doi: 10.12659/MSM.893925.
6
Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Head Neck Pathol. 2023 Dec;17(4):961-968. doi: 10.1007/s12105-023-01600-7. Epub 2023 Nov 28.
7
Protein Cargo of Salivary Small Extracellular Vesicles as Potential Functional Signature of Oral Squamous Cell Carcinoma.
Int J Mol Sci. 2021 Oct 16;22(20):11160. doi: 10.3390/ijms222011160.
8
Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
Cancer Prev Res (Phila). 2018 Aug;11(8):491-502. doi: 10.1158/1940-6207.CAPR-17-0409. Epub 2018 May 15.
9
Salivary Circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as Novel Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma.
Cell Physiol Biochem. 2018;47(6):2511-2521. doi: 10.1159/000491624. Epub 2018 Jul 10.
10
Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
BMC Cancer. 2018 Apr 18;18(1):439. doi: 10.1186/s12885-018-4364-z.
引用本文的文献
1
Serum from patients with oral squamous cell carcinoma remodels the tumor immune escape ecological niche by promoting regulatory T‑cell differentiation and T‑cell exhaustion.
Oncol Rep. 2025 Nov;54(5). doi: 10.3892/or.2025.8978. Epub 2025 Aug 29.
2
Biosensors based on organic transistors for intraoral biomarker detection.
Mikrochim Acta. 2025 May 5;192(6):335. doi: 10.1007/s00604-025-07189-8.
3
Expression and mechanism of PRDXs family in oral squamous cell carcinoma.
Discov Oncol. 2025 Mar 28;16(1):415. doi: 10.1007/s12672-025-01872-1.
4
Salivary miRNAs and cytokines associated with diagnosis and prognosis of oral squamous cell carcinoma.
Front Cell Dev Biol. 2025 Jan 22;13:1531016. doi: 10.3389/fcell.2025.1531016. eCollection 2025.
5
Salivary diagnostics: opportunities and challenges.
Theranostics. 2024 Oct 21;14(18):6969-6990. doi: 10.7150/thno.100600. eCollection 2024.
6
Caveolin-1 modulates cisplatin sensitivity in oral squamous cell carcinoma through ferroptosis.
Clin Transl Oncol. 2025 May;27(5):2160-2173. doi: 10.1007/s12094-024-03724-w. Epub 2024 Sep 26.
7
Identification of Stage-Specific microRNAs that Govern the Early Stages of Sequential Oral Oncogenesis by Strategically Bridging Human Genetics with Epigenetics and Utilizing an Animal Model.
Int J Mol Sci. 2024 Jul 12;25(14):7642. doi: 10.3390/ijms25147642.
8
Strategic approaches in oral squamous cell carcinoma diagnostics using liquid biopsy.
Periodontol 2000. 2024 Oct;96(1):316-328. doi: 10.1111/prd.12567. Epub 2024 Apr 27.
9
Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance.
Int J Mol Sci. 2024 Feb 10;25(4):2167. doi: 10.3390/ijms25042167.
10
Network pharmacology and experiment validation investigate the potential mechanism of triptolide in oral squamous cell carcinoma.
Front Pharmacol. 2024 Jan 8;14:1302059. doi: 10.3389/fphar.2023.1302059. eCollection 2023.
本文引用的文献
1
Inflammatory Mediators in Oral Cancer: Pathogenic Mechanisms and Diagnostic Potential.
Front Oral Health. 2021 Feb 22;2:642238. doi: 10.3389/froh.2021.642238. eCollection 2021.
2
Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review.
Int J Mol Sci. 2021 Jun 24;22(13):6795. doi: 10.3390/ijms22136795.
3
Salivary exosomal microRNAs as biomarkers for head and neck cancer detection-a literature review.
Maxillofac Plast Reconstr Surg. 2021 Jun 30;43(1):19. doi: 10.1186/s40902-021-00303-9.
4
Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma.
J Clin Med. 2021 Apr 13;10(8):1658. doi: 10.3390/jcm10081658.
5
Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets.
Genes (Basel). 2021 Mar 15;12(3):422. doi: 10.3390/genes12030422.
6
The role of differentially expressed salivary microRNA in oral squamous cell carcinoma. A systematic review.
Arch Oral Biol. 2021 May;125:105108. doi: 10.1016/j.archoralbio.2021.105108. Epub 2021 Mar 18.
7
Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study.
PLoS One. 2021 Mar 18;16(3):e0248167. doi: 10.1371/journal.pone.0248167. eCollection 2021.
8
Blood and Salivary MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
J Oral Maxillofac Surg. 2021 May;79(5):1082.e1-1082.e13. doi: 10.1016/j.joms.2020.12.043. Epub 2020 Dec 30.
9
The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis.
Cancer Med. 2020 Nov;9(22):8333-8344. doi: 10.1002/cam4.3440. Epub 2020 Oct 13.
10
Tumour-associated tissue eosinophilia (TATE) in oral squamous cell carcinoma: a comprehensive review.
Histol Histopathol. 2021 Feb;36(2):113-122. doi: 10.14670/HH-18-250. Epub 2020 Sep 28.
Zotero 插件